Aims and objectives
To determine the usefulness of a program for early identification of Interstitial Lung Diseases (ILDs) emphasizing on Idiopathic Pulmonary Fibrosis (IPF),
attending to the benefits of an earlier diagnosis and new therapeutic options.
Methods and materials
Retrospective study of all consecutive cases referred through a rapid circuit from Primary Care (PC) centers to the ILD Unit from 2012 to 2015.
The PC physicians and PC radiologists were trained in ILD identification during the year before the recruitment started.
Patients attending to PC centers were included in our study following two possible paths:
the PC physician requested a chest x-ray,
and in case of ILD suspicion,
the PC radiologist requested a chest high resolution computed tomography (HRCT).
the PC physician directly requested...
Results
(The results of our study are shown in figure 1).
Our study included a total of 62 patients,
with a mean age of 71 years old (standard deviation 11 years).
The male-to-female ratio was 1,8:1.
Forty patients had smoking history (64,5%),
with a median of 40 pack-years.
Life-limiting comorbidities (cancer,
ischemic cardiopathy,
stroke,
degenerative disease,
history of a high-risk surgery) were present in 21 patients (33,8%).
Functionally,
the patients had preserved FVC (mean of 93,3% of the expected value) and mild-to-moderate decrease of DLCO (65,8%)....
Conclusion
A program for early ILD identification in primary care centers associates a high rate of diagnosis and optimizing treatment.
However,
a proportion of patients do not benefit from this program because of advanced age and comorbidities.
References
1.
Fischer A,
Antoniou KM,
Brown KK,
Cadranel J,
Corte TJ,
Du Bois RM,
Lee JS,
Leslie KO,
Lynch DA,
Matteson EL,
Mosca M,
Noth I,
Richeldi L,
Strek ME,
Swigris JJ,
Wells AU,
West SG,
Collard HR and Cottin V,
on behalf of the “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”.
An official European Respiratory Society/ American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Eur Respir J 2015; 46: 976–987
2.
Copley SJ,
Wells AU,
Hawtin KE,
Gibson DJ,
Hodson JM,...